(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 49.99% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.84%.
Fortress Biotech's revenue in 2025 is $62,501,000.On average, 2 Wall Street analysts forecast FBIO's revenue for 2025 to be $4,297,122,051, with the lowest FBIO revenue forecast at $3,610,725,367, and the highest FBIO revenue forecast at $4,983,518,735. On average, 2 Wall Street analysts forecast FBIO's revenue for 2026 to be $5,476,542,856, with the lowest FBIO revenue forecast at $4,336,735,131, and the highest FBIO revenue forecast at $6,616,350,581.
In 2027, FBIO is forecast to generate $5,487,860,879 in revenue, with the lowest revenue forecast at $5,487,860,879 and the highest revenue forecast at $5,487,860,879.